Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02038166 · ClinicalTrials.gov registry record
Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis
A clinical trial of Rhinosinusitis, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT02038166 is a study of Rhinosinusitis that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02038166, a study of Rhinosinusitis, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if acquired (partial) Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) deficiency contributes substantially to the pathogenic mechanisms underlying Chronic Rhinosinusitis (CRS), creating a localized environment that impairs mucociliary clearance (MCC).
Conditions Studied
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-01 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02038166
The ClinicalTrials.gov registry entry for NCT02038166 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rhinosinusitis appearing as the primary indexed condition, and to 0 interventions.
NCT02038166 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT02038166 about?
NCT02038166 is a clinical study titled "Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis". The purpose of this study is to determine if acquired (partial) Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) deficiency contributes substantially to the pathogenic mechanisms underlying Chronic Rhinosinusitis (CRS), creating a localized environment that impairs mucociliary clearance (M...
What is the current status of trial NCT02038166?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2015-01. Estimated completion is 2027-12.
What conditions does trial NCT02038166 study?
This clinical trial studies the following conditions: Rhinosinusitis.
Who is sponsoring clinical trial NCT02038166?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02038166 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rhinosinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.